Cerebriu
Cerebriu is a health tech company focused on expanding MRI accessibility through advanced AI technology. Their flagship product, Apollo, is an AI-based software suite designed to optimize brain MRI workflows by providing real-time alerts on critical conditions such as infarcts, intracranial hemorrhages, and tumors during scans. Apollo enhances MRI workflow efficiency from image acquisition to diagnosis by enabling on-table detection, prioritized reading, and real-time protocol adaptation. The company targets hospitals, radiology centers, stroke centers, and teleradiology providers, offering tailored AI solutions that integrate seamlessly into MRI scanners or AI platforms. Cerebriu's business model includes SaaS and custom AI solution development for OEM partners, enabling scalable AI integration without additional hardware. The company is positioned as a leader in AI-driven radiology workflow solutions with regulatory compliance in the EU and partnerships with AI platforms and distributors.
Cerebriu
Cerebriu is a health tech company focused on expanding MRI accessibility through advanced AI technology. Their flagship product, Apollo, is an AI-based software suite designed to optimize brain MRI workflows by providing real-time alerts on critical conditions such as infarcts, intracranial hemorrhages, and tumors during scans. Apollo enhances MRI workflow efficiency from image acquisition to diagnosis by enabling on-table detection, prioritized reading, and real-time protocol adaptation. The company targets hospitals, radiology centers, stroke centers, and teleradiology providers, offering tailored AI solutions that integrate seamlessly into MRI scanners or AI platforms. Cerebriu's business model includes SaaS and custom AI solution development for OEM partners, enabling scalable AI integration without additional hardware. The company is positioned as a leader in AI-driven radiology workflow solutions with regulatory compliance in the EU and partnerships with AI platforms and distributors.
TL;DR
Founded / HQ: 2018; Copenhagen, Denmark
Product: Apollo — AI suite for real-time brain MRI triage, on-table protocol adaptation, and prioritized reading
Employees: 55
Recent raise: Series A announced 12 Sep 2024 (led by North Ventures)
Regulatory status: CE-marked product
Company Overview
Problem Domain
Automating and optimizing brain MRI workflows to improve timely detection and radiology workflow efficiency.
Founded
2018
Industry
Healthtech / Medical imaging AI
Funding Track Record
Seed reported as 2 million; investors named include KMD Venture, Crista Galli Ventures, Vaekstfonden and angels
Series A announced 12 Sep 2024 with participation from Sagitta Ventures and Export and Investment Fund
Investor Signal
“North Ventures led Series A; continued support from EIFO and Sagitta Ventures”